Team:Freiburg/Sponsors
From 2011.igem.org
(Difference between revisions)
Line 51: | Line 51: | ||
We are on a strong technological basis in SYNTHETIC BIOLOGY focusing on synthetic genes, gene | We are on a strong technological basis in SYNTHETIC BIOLOGY focusing on synthetic genes, gene | ||
and gene cluster designs, multi-protein-expression and bio-molecule separation technologies. | and gene cluster designs, multi-protein-expression and bio-molecule separation technologies. | ||
- | <br><br> | + | <br/><br/> |
(1) ATG:biosynthetics uses computational methods based on the proprietary evoMAG software package. | (1) ATG:biosynthetics uses computational methods based on the proprietary evoMAG software package. | ||
Optimal functional DNA sequence features of genes mostly are conflicting in target functions. | Optimal functional DNA sequence features of genes mostly are conflicting in target functions. | ||
Line 59: | Line 59: | ||
Genetic algorithms for parallel optimization of multiple sequence features are applied. | Genetic algorithms for parallel optimization of multiple sequence features are applied. | ||
We help making gene expression more reliable by avoiding malfunction. | We help making gene expression more reliable by avoiding malfunction. | ||
- | <br><br> | + | <br/><br/> |
(2) ATG’s Synthetic Biology “Application Builder” tools is online available as a design tool | (2) ATG’s Synthetic Biology “Application Builder” tools is online available as a design tool | ||
for setting up customer projects and providing genetic building blocks libraries. | for setting up customer projects and providing genetic building blocks libraries. | ||
Line 66: | Line 66: | ||
paradigm Artemisinin (a drug used to treat multi-drug resistant malaria). | paradigm Artemisinin (a drug used to treat multi-drug resistant malaria). | ||
ATG at present is involved in pathway designs for Polyketides and Mevalonate paths and others… | ATG at present is involved in pathway designs for Polyketides and Mevalonate paths and others… | ||
- | <br><br> | + | <br/><br/> |
(3) With the ACEMBL - technology ATG is focused on “Multiple Gene/ Protein Expression Systems” | (3) With the ACEMBL - technology ATG is focused on “Multiple Gene/ Protein Expression Systems” | ||
Multiple gene expression is available for E. coli, Baculovirus infected Insect cells and for Mammalian systems. | Multiple gene expression is available for E. coli, Baculovirus infected Insect cells and for Mammalian systems. | ||
ACEMBL CLASSIC can be adapted for many more organisms. TOGGLE –ACEMBL allows the assembly of | ACEMBL CLASSIC can be adapted for many more organisms. TOGGLE –ACEMBL allows the assembly of | ||
many expression cassettes for the design of pathways and protein complex structures. | many expression cassettes for the design of pathways and protein complex structures. | ||
- | <br><br> | + | <br/><br/> |
(4) Purification of bio-molecules can easily be performed with the MONOLITH - technology in | (4) Purification of bio-molecules can easily be performed with the MONOLITH - technology in | ||
industrial scales. The advantages of MONOTITH are in separation speed increase due | industrial scales. The advantages of MONOTITH are in separation speed increase due | ||
Line 85: | Line 85: | ||
</table> | </table> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</html> | </html> | ||
{{:Team:Freiburg/Templates/footer}} | {{:Team:Freiburg/Templates/footer}} |
Revision as of 12:20, 29 July 2011